164 related articles for article (PubMed ID: 34978007)
1. Investigation of the structure-activity relationship in a series of new LVV- and VV-hemorphin-7 analogues designed as potential anticonvulsant agents.
Todorov P; Georgieva S; Peneva P; Tchekalarova J
Amino Acids; 2022 Feb; 54(2):261-275. PubMed ID: 34978007
[TBL] [Abstract][Full Text] [Related]
2. Potential anticonvulsant activity of novel VV-hemorphin-7 analogues containing unnatural amino acids: synthesis and characterization.
Todorov P; Peneva P; Tchekalarova J; Georgieva S
Amino Acids; 2020 Apr; 52(4):567-585. PubMed ID: 32206933
[TBL] [Abstract][Full Text] [Related]
3. Anticonvulsant evaluation and docking analysis of VV-Hemorphin-5 analogues.
Todorov P; Rangelov M; Peneva P; Todorova N; Tchekalarova J
Drug Dev Res; 2019 Jun; 80(4):425-437. PubMed ID: 30681179
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and anticonvulsant activity of new series of N-modified analogues of VV-hemorphin-5 with aminophosphonate moiety.
Todorov P; Peneva P; Tchekalarova J; Rangelov M; Georgieva S; Todorova N
Amino Acids; 2019 Nov; 51(10-12):1527-1545. PubMed ID: 31576456
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship study on new hemorphin-4 analogues containing steric restricted amino acids moiety for evaluation of their anticonvulsant activity.
Todorov P; Peneva P; Tchekalarova J; Georgieva S; Rangelov M; Todorova N
Amino Acids; 2020 Oct; 52(10):1375-1390. PubMed ID: 33011823
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular docking, electrochemical and fluorimetric analysis of new caffeic and cinnamic acid-conjugated hemorphin derivatives designed as potential anticonvulsant and antinociceptive agents.
Todorov P; Georgieva S; Peneva P; Nikolov S; Rangelov M; Todorova N; Pechlivanova D; Tchekalarova J
Bioorg Chem; 2024 Feb; 143():107063. PubMed ID: 38150935
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and anticonvulsant activity of new azobenzene-containing VV-hemorphin-5 bio photoswitch.
Todorov PT; Peneva PN; Georgieva SI; Tchekalarova J; Vitkova V; Antonova K; Georgiev A
Amino Acids; 2019 Mar; 51(3):549-563. PubMed ID: 30604096
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain.
Assenov B; Pechlivanova D; Dzhambazova E; Peneva P; Todorov P
Protein Pept Lett; 2021; 28(4):442-449. PubMed ID: 32798365
[TBL] [Abstract][Full Text] [Related]
9. Kinetic studies on aminopeptidase M-mediated degradation of human hemorphin LVV-H7 and its N-terminally truncated products.
John H; John S; Forssmann WG
J Pept Sci; 2008 Jul; 14(7):797-803. PubMed ID: 18236385
[TBL] [Abstract][Full Text] [Related]
10. Mechanochemical synthesis and anticonvulsant activity of 3-aminopyrrolidine-2,5-dione derivatives.
Jarzyński S; Rapacz A; Dziubina A; Pękala E; Popiół J; Piska K; Wojtulewski S; Rudolf B
Biomed Pharmacother; 2023 Dec; 168():115749. PubMed ID: 37879208
[TBL] [Abstract][Full Text] [Related]
11. LVV- and VV-hemorphins: comparative levels in rat tissues.
Yatskin ON; Philippova MM; Blishchenko EYu ; Karelin AA; Ivanov VT
FEBS Lett; 1998 May; 428(3):286-90. PubMed ID: 9654150
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements and mechanism of the pressor activity of Leu-Val-Val-hemorphin-7, a fragment of hemoglobin beta-chain in rats.
Moisan S; Harvey N; Beaudry G; Forzani P; Burhop KE; Drapeau G; Rioux F
Peptides; 1998; 19(1):119-31. PubMed ID: 9437744
[TBL] [Abstract][Full Text] [Related]
13. Kinetic of in vitro generation of some hemorphins: early release of LVV-hemorphin-7, precursor of VV-hemorphin-7.
Dagouassat N; Garreau I; Zhao Q; Sannier F; Piot JM
Neuropeptides; 1996 Feb; 30(1):1-5. PubMed ID: 8868292
[TBL] [Abstract][Full Text] [Related]
14. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures.
Blishchenko EY; Sazonova OV; Kalinina OA; Yatskin ON; Philippova MM; Surovoy AY; Karelin AA; Ivanov VT
Peptides; 2002 May; 23(5):903-10. PubMed ID: 12084521
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and evaluation of anti-hyperalgesia, anticonvulsant and antioxidant activity of novel VV-hemorphin-5 analogs.
Todorov P; Georgieva S; Tchekalarova J; Peneva P; Mateeva P; Assenov B; Dzhambazova E; Pechlivanova D
Arch Pharm (Weinheim); 2023 Oct; 356(10):e2300267. PubMed ID: 37532631
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization and nociceptive screening of new VV-hemorphin-5 analogues.
Todorov P; Peneva P; Pechlivanova D; Georgieva S; Dzhambazova E
Bioorg Med Chem Lett; 2018 Oct; 28(18):3073-3079. PubMed ID: 30078474
[TBL] [Abstract][Full Text] [Related]
17. Design and Synthesis of 5-Substituted Benzo[d][1,3]dioxole Derivatives as Potent Anticonvulsant Agents.
Dong S; Wang T; Hu C; Chen X; Jin Y; Wang Z
Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28092111
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anticonvulsant properties of new N-Mannich bases derived from 3-phenylpyrrolidine-2,5-diones.
Kamiński K; Obniska J; Chlebek I; Wiklik B; Rzepka S
Bioorg Med Chem; 2013 Nov; 21(21):6821-30. PubMed ID: 23993970
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticonvulsant activity of N-(2-hydroxyethyl) cinnamamide derivatives.
Guan LP; Wei CX; Deng XQ; Sui X; Piao HR; Quan ZS
Eur J Med Chem; 2009 Sep; 44(9):3654-7. PubMed ID: 19272675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
